Lv1
60 积分 2021-07-26 加入
Oral versus intravenous vinorelbine: clinical safety profile
8天前
已完结
Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer
24天前
已完结
Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?
1个月前
已完结
A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study
3个月前
已完结
Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???
3个月前
已完结
Efficacy and safety of concomitant chemo-endocrine therapy in neoadjuvant treatment of hormone-positive HER2-negative breast cancer: a systematic review and meta-analysis
3个月前
已完结
The potential of lenvatinib in breast cancer therapy
4个月前
已完结
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
5个月前
已完结
Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first‐line treatment of patients with advanced breast cancer: Phase 3 randomized trial
5个月前
已完结
Subcutaneous Trastuzumab (scT) and metronomic oral Vinorelbine (mVRL) combination in HER2 + ve advanced breast cancer (ABC) patients (pts): a pilot evaluation of toxicity. Preliminary results of the VICTOR-4 study
5个月前
已完结
皖公网安备34019202002308
